Question 1 · Hard
Histopathology after wide excision of a buccal mucosa cancer with a modified radical neck dissection: tumour 3.5 cm, depth of invasion 9 mm, all mucosal and deep margins clear by more than 5 mm, perineural invasion absent; 2 of 31 nodes positive, one showing tumour breaching the nodal capsule into the surrounding fat. The patient has recovered well and has normal renal function and hearing. What is the best adjuvant treatment?
- AObservation with 3-monthly review
- BRadiotherapy with concurrent cisplatin
- CRadiotherapy alone
- DOral metronomic chemotherapy
Show answerHide answer
Answer: B · Radiotherapy with concurrent cisplatin
Extranodal extension (tumour breaching the node capsule) and a positive margin are the two high-risk features after head and neck cancer surgery. The EORTC 22931 and RTOG 9501 trials showed that adding concurrent cisplatin to postoperative radiotherapy improves locoregional control and survival in this group. Radiotherapy alone suits intermediate-risk features such as multiple nodes without extranodal extension. Key point: Extranodal extension or a positive margin after head and neck cancer surgery needs postoperative chemoradiotherapy with cisplatin.
- A: Observation is unsafe with two positive nodes and extranodal extension.
- C: Radiotherapy alone is for intermediate risk; extranodal extension needs added cisplatin.
- D: Metronomic chemotherapy is a palliative option, not standard adjuvant therapy.